Syzygium aromaticum as a possible source of SARS-CoV-2 main protease inhibitors: Evidence from a computational investigation

Q3 Biochemistry, Genetics and Molecular Biology Journal of Advanced Biotechnology and Experimental Therapeutics Pub Date : 2022-01-01 DOI:10.5455/jabet.2022.d109
M. Ali, A-Zha Nur, Rubaeit Rakib, M. Khatun, R. Hasib, M. Rahman, M. Alam, Md Abdullah Al Mashud, Mohammad Jamal
{"title":"Syzygium aromaticum as a possible source of SARS-CoV-2 main protease inhibitors: Evidence from a computational investigation","authors":"M. Ali, A-Zha Nur, Rubaeit Rakib, M. Khatun, R. Hasib, M. Rahman, M. Alam, Md Abdullah Al Mashud, Mohammad Jamal","doi":"10.5455/jabet.2022.d109","DOIUrl":null,"url":null,"abstract":"SARS-CoV-2, a new and fast circulating coronavirus strain, infected over 214 countries and territories worldwide and caused global health emergencies. The absence of appropriate medicines and vaccinations has further complicated the condition. SARS-CoV-2 main protease (Mpro) is crucial for its propagation, and it is considered a striking target. This study used several computational approaches to determine the probable antagonist of SARS-CoV-2 Mpro from bioactive phytochemicals of Syzygium aromaticum. A total of 20 compounds were screened through in silico approach. The molecular dynamics simulation studies were then carried out for further insights. We found crategolic acid, oleanolic acid, and kaempferol have considerable binding affinity and important molecular contacts with catalytic pocket residues, His41-Cys145. The pharmacological properties through ADMET analysis also showed that these compounds could be used as safe drug candidates. The molecular dynamics simulation study further confirmed these compound's stability with Mpro. However, further detailed in-vitro and in-vivo analyses are compulsory to evaluate the real potentiality of identified compounds.","PeriodicalId":36275,"journal":{"name":"Journal of Advanced Biotechnology and Experimental Therapeutics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Biotechnology and Experimental Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/jabet.2022.d109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

SARS-CoV-2, a new and fast circulating coronavirus strain, infected over 214 countries and territories worldwide and caused global health emergencies. The absence of appropriate medicines and vaccinations has further complicated the condition. SARS-CoV-2 main protease (Mpro) is crucial for its propagation, and it is considered a striking target. This study used several computational approaches to determine the probable antagonist of SARS-CoV-2 Mpro from bioactive phytochemicals of Syzygium aromaticum. A total of 20 compounds were screened through in silico approach. The molecular dynamics simulation studies were then carried out for further insights. We found crategolic acid, oleanolic acid, and kaempferol have considerable binding affinity and important molecular contacts with catalytic pocket residues, His41-Cys145. The pharmacological properties through ADMET analysis also showed that these compounds could be used as safe drug candidates. The molecular dynamics simulation study further confirmed these compound's stability with Mpro. However, further detailed in-vitro and in-vivo analyses are compulsory to evaluate the real potentiality of identified compounds.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
丁香作为SARS-CoV-2主要蛋白酶抑制剂的可能来源:来自计算调查的证据
SARS-CoV-2是一种快速传播的新型冠状病毒毒株,已在全球214多个国家和地区感染,并引发全球突发卫生事件。缺乏适当的药物和疫苗接种使病情进一步复杂化。SARS-CoV-2主蛋白酶(Mpro)对其繁殖至关重要,被认为是一个引人注目的靶标。本研究使用了几种计算方法,从丁香的生物活性植物化学物质中确定可能的SARS-CoV-2 Mpro拮抗剂。通过硅法共筛选了20个化合物。然后进行分子动力学模拟研究以进一步了解。我们发现,十一烯酸、齐墩果酸和山奈酚与催化口袋残基His41-Cys145具有相当大的结合亲和力和重要的分子接触。通过ADMET分析的药理学性质也表明这些化合物可以作为安全的候选药物。分子动力学模拟研究进一步证实了这些化合物与Mpro的稳定性。然而,进一步详细的体外和体内分析是必要的,以评估鉴定的化合物的真正潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Advanced Biotechnology and Experimental Therapeutics
Journal of Advanced Biotechnology and Experimental Therapeutics Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
1.90
自引率
0.00%
发文量
41
审稿时长
8 weeks
期刊最新文献
Assessment of antiproliferative and toxic effects of a peptide from Momordica dioica using in vitro and in vivo studies Investigation of the relationship between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase with SARS CoV-2 infections Anti-inflammatory and anti-microbial activities of the phytochemicals isolated from various parts of broccoli wastes Epidemiological burden, risk factors, and recent therapeutic advances in chronic obstructive pulmonary disease The potentials of Pangi leaf extract for Aedes spp. mosquito control
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1